0

HB-EGF human

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATIAR42413234
Descriptionrecombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC), suitable for cell culture
Assay≥95% (HPLC); ≥95% (SDS-PAGE)
Colorwhite to off-white
Formlyophilized
Impurity Content<0.1 EU/μg endotoxin, tested
Size50μG
Storage Conditions−20°C
1

A Novel Anti-Human HB-EGF Monoclonal Antibody With Multiple Antitumor Mechanisms Against Ovarian Cancer Cells

Shingo Miyamoto, Ryo Iwamoto, Akiko Furuya, Kumiko Takahashi, Yuka Sasaki, Hiroshi Ando, Fusanori Yotsumoto, Tomoko Yoneda, Miki Hamaoka, Hiroshi Yagi, Takuya Murakami, Sayaka Hori, Kenya Shitara, Eisuke Mekada

Clin Cancer Res. 2011 Nov 1;17(21):6733-41.

PMID: 21918176

1

Anti-HB-EGF Antibody-Mediated Delivery of siRNA to Atherosclerotic Lesions in Mice

Shota Tsuchida, Takashi Matsuzaki, Masaki Yamato, Keiji Okuda, Hai Ying Fu, Ryo Araki, Shoji Sanada, Hiroshi Asanuma, Yoshihiro Asano, Masanori Asakura, Hiroyuki Hao, Seiji Takashima, Masafumi Kitakaze, etc.

Int Heart J. 2018 Nov 28;59(6):1425-1431.

PMID: 30393262

1

Anti-Human HB-EGF Monoclonal Antibody

Monoclon Antib Immunodiagn Immunother. 2016 Apr;35(2):123.

PMID: 27097072

1

HB-EGF Is Associated With DNA Damage and Mcl-1 Turnover in Human Glioma Cell Lines Treated by Temozolomide

Quentin Séry, Marion Rabé, Lisa Oliver, François M Vallette, Catherine Gratas

Biochem Biophys Res Commun. 2017 Dec 2;493(4):1377-1383.

PMID: 28970067

1

Validity of HB-EGF as Target for Human Neuroblastoma Therapy

Sung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, Ryota Souzaki, Tomoaki Taguchi, Masahide Kuroki, Shingo Miyamoto

Anticancer Res. 2015 Aug;35(8):4433-40.

PMID: 26168483

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode